About this episode
In a mere nine months, Eli Lilly accomplished an unprecedented feat: The drug giant took a blood sample from one of the first U.S. patients to recover from Covid-19, identified an antibody that could fight the virus, and created a version of the antibody to treat people with the disease. Riley Griffin spoke to Lilly's CEO David Ricks about the challenges facing the company and its new treatment amid the worsening pandemic.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Prognosis: Misconception publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Prognosis: Misconception
Introducing: Levittown
Prognosis: Misconception
Listen Now: Beak Capitalism from Odd Lots
Prognosis: Misconception
Misconception: Great Expectations
Prognosis: Misconception
Misconception: Big Baby
Prognosis: Misconception